INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,846,000 | -59.8% | 39,164 | -34.5% | 0.00% | -75.0% |
| Q4 2021 | $7,072,000 | -35.3% | 59,814 | -26.6% | 0.00% | -33.3% |
| Q3 2021 | $10,937,000 | +2.6% | 81,531 | +23.8% | 0.01% | 0.0% |
| Q2 2021 | $10,665,000 | +383.0% | 65,872 | +139.5% | 0.01% | +500.0% |
| Q1 2021 | $2,208,000 | +93.2% | 27,507 | +30.9% | 0.00% | 0.0% |
| Q4 2020 | $1,143,000 | +227.5% | 21,007 | +19.6% | 0.00% | – |
| Q3 2020 | $349,000 | -1.7% | 17,569 | +4.1% | 0.00% | – |
| Q2 2020 | $355,000 | +54.3% | 16,876 | -10.2% | 0.00% | – |
| Q1 2020 | $230,000 | -67.8% | 18,800 | -61.4% | 0.00% | -100.0% |
| Q4 2019 | $714,000 | +303.4% | 48,681 | +267.0% | 0.00% | – |
| Q3 2019 | $177,000 | -14.9% | 13,263 | +4.3% | 0.00% | – |
| Q2 2019 | $208,000 | -22.4% | 12,720 | -18.8% | 0.00% | – |
| Q1 2019 | $268,000 | -35.3% | 15,673 | +8.3% | 0.00% | – |
| Q3 2018 | $414,000 | +25.1% | 14,466 | +19.5% | 0.00% | – |
| Q2 2018 | $331,000 | – | 12,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |